RapidFor™ SARS-CoV-2 & FLU A/B Antigen Combo Test Kit uses the colloidal gold as a tool to detect the SARS-CoV-2 antigen test and the FLU A/B antigen detection in the collected nasopharyngeal and nasal swab specimens.
– Easy to use and read
– 2 in 1 test for Influenza and SARS-CoV-2
– No extra lab equipment
– Variant Detection [B.1.1.7 (Alpha), B.1.351 (Beta), E484K mutation,
B1.617.2 (Delta), P.1 (Gamma), C.37 (Lambda), B.1.1.529 (Omicron)]
– Early phase detection
– Suitable for rapid screening a large number of people
– Test Cassette
– Extraction Buffer
– User Manual
– External Positive Control (Optional)*
|Intended use||Detection of SARS-CoV-2 & FLU A/B Combo Antigen|
|Storage||2-30℃ / 35.6-86℉|
|Time to result||15 minutes|
|Shelf life||24 months|
|Sensitivity Influenza A||98.90%|
|Specificity Influenza A||99.52%|
|Sensitivity Influenza B||98.80%|
|Specificity Influenza B||99.52%|
|Sensitivity Cov-19 Ag||98.94%|
|Specificity Cov-19 Ag||99.52%|
Symptoms of COVID-19 can easily be mistaken for influenza. Especially for patients presenting with COVID-like symptoms such as fever, dry cough, sore throat, headache, congested/runny nose, and fatigue, timely diagnosis and intervention are critical for the prevention of further transmission and the initiation of treatment. With RapidFor™ Flu A/B Rapid Antigen Test Kit, you can check for and differentiate between infections with SARS-CoV-2 and influenza.
SARS-CoV-2 and influenza are common, highly infectious, and potentially consequential diseases with similar signs and symptoms. Thus, it may be highly challenging to differentiate infections with SARS-CoV-2 and influenza without the use of diagnostic tests. Especially during flu seasons, when these viruses may be circulating simultaneously, the differential diagnosis of SARS-CoV-2 and influenza proves to be critical for the initiation of immediate isolation and optimal treatment.
The sensitivity of the test kit for SARS-CoV-2 is 99.16%
The sensitivity of the test kit for Influenza A is 99.35%
The sensitivity of the test kit for Influenza B is 98.76%
The specificity of the test kit is 99.75%.
The sensitivity of the test kit for SARS-CoV-2 is 98.74%
The sensitivity of the test kit for Influenza A is 98.69%
The sensitivity of the test kit for Influenza B is 98.19%.
The specificity of the test kit is 99.50%.
Yes, RapidFor™ SARS-CoV-2 & FLU A/B Combo Antigen Test Kit can successfully detect infections with SARS-CoV-2 and influenza as early as 2-4 days after viral exposure.
Our examinations have shown that our test kits can detect current variants of SARS-CoV-2, including B.1.1.7 UK (Alpha), B.1.351 South Africa (Beta), E484K mutation, B1.617.2 India (Delta), P.1 Brazil (Gamma), C.37 (Lambda), and B.1.1.529 (Omicron) strains.
SARS-CoV-2 & FLU A/B Combo Antigen Test Kit offers many unique benefits for public health. As common and consequential infections with similar symptoms, the clinical diagnosis of COVID-19 and influenza may be challenging. SARS-CoV-2 & FLU A/B Combo Antigen Test Kit enables the rapid detection and differentiation of infections with SARS-CoV-2 and Influenza A/B. Further, unlike RT-PCR tests, SARS-CoV-2 & FLU A/B Combo Antigen Test Kit can detect infections with SARS-CoV-2 in just a few minutes, which reduces turnaround time, ensures immediate isolation, prevents further transmission, and aids the initiation of optimal treatment.
RapidFor™ SARS-CoV-2 & FLU A/B Combo Antigen Test Kit allows for safe, non-invasive, and pain-free sample collection with user-friendly nasal and nasopharyngeal swabs. Please follow the instructions carefully to ensure maximum safety, comfort, and accuracy. While mild discomfort is possible during sample collection, make sure to stop the procedure and seek medical help if you experience any pain.
A positive result with RapidFor™ SARS-CoV-2 & FLU A/B Combo Antigen Test Kit is indicative of active infection with SARS-CoV-2 and or influenza A/B. If you have tested positive for SARS-CoV-2, please go into quarantine and contact your healthcare provider. A confirmatory test by using an RT-PCR test may be necessary. If you have tested positive for influenza, you may consider seeking medical support depending on your health status, immunity status, and symptom severity.
Please read the instruction manual thoroughly before starting the procedure. The procedure should be concluded within 15 minutes after the test cassette is removed from the foil package. Please make sure to recap the buffer solution quickly after each use and utilize the sample as soon as possible. The sample should be used within 20 minutes at most, inactivation of samples is not recommended.
No, RapidFor™ SARS-CoV-2 & FLU A/B Combo Antigen Test Kit is designed for one-time use only.
RapidFor™ SARS-CoV-2 & FLU A/B Combo Antigen Test Kit can be stored be between 2°C-30°C and within 40-60% of humidity in the sealed package until its expiration date. Please make sure to check the label on the packaging for the manufacturing and expiration dates. Do not store the kit below 2°C or use it after expired date.
A negative test result by RapidFor™ SARS-CoV-2 & FLU A/B Combo Antigen Test Kit does not completely exclude an infection with SARS-CoV-2 or influenza. You may consider taking another test within 4 to 5 days. Complementary testing with RT-PCR tests may also be required to rule out the risk of infection with SARS-CoV-2. Please remember to maintain social distancing, contact your healthcare provider, and seek medical help if necessary.
After the process, all samples and materials should be placed in the aluminum foil and disposed of as biohazardous waste as soon as possible. Please refrain from using the recycling bin for disposal and make sure that animals and children are out of reach.